cassettes, each containing 1080 bp, with 80 bp overlap to adjacent cassettes, and they were individually synthesized by chemical approach. Ten cassettes were recombined in yeast to yield the 10-kb intermediates, which were further recombined to obtain the 100-kb intermediates and the final complete genome. The correct assembly was confirmed by both multiplex PCR and restriction analysis, and the synthetic M. mycoide genomes were transplanted into restriction-minus Mycoplasma capricolum recipient cells. Bacteria with synthetic genomes were screened by tetracycline and X-gal as designed, and were also verified by multiplex PCR, restriction analysis, whole genome sequencing (the sequenced strain was referred as M. mycoides JCVI-syn1.0), etc. Under the experimental condition, the cells with only synthetic genome were able to perform self-replication and logarithmic growth. Proteomics analysis revealed that these cells have nearly identical protein expression pattern as the genome donor, M. mycoide, but not the recipient, M. capricolum.
Shortly after the announcement of this result, the scanning and transmission electron micrograph of synthetic M. mycoide has become a most popular image around the world. This "artificial" life is a hallmark on both conceptual and technical aspects. DNA is supposed to contain all the genetic information for life. It is a complicated process to obtain accurate whole genome sequence and to synthesize an error-free genome with rounds of manipulation before final transplantation. Such work requires high-throughput sequencing facilities, innumerous data processing, sophisticated designing strategy, precise chemical synthesis, multiple steps of quality control, etc. The success of synthetic M. mycoides reveals the power of current biotechnology to accomplish such a marvelous project. In addition, it proves the principle of producing cells from computer-designed genome rather than modifying DNA sequence by traditional insertion, deletion or mutagenesis. At current moment, the M. mycoides with synthetic genome is almost identical to the naturally existing M. mycoides; it opens the door for scientists to make synthetic cells with distinguished, predicted and/or even unnatural properties. Although ethical concerns have emerged, such as its potential application on bioterrorism, the technique will have significant implications in pharmaceutical field, environmental science, clean energy, food industry, etc.
In spite that the synthetic M. mycoides is called "synthetic cell" and its DNA bases are solely synthesized by chemical approach, the process still relies highly on life components. First, the synthetic DNA fragments, including the 1080-bp DNA cassettes, 10-kb intermediates and 100-kb intermediates, were assembled in yeast cells, in which these pieces were recombined together to finally form a complete functional genome. The pathway and regulation of such recombination in yeast is not well understood. Whether the assembly can be finished in a life-free or a synthetic microenvironment remains to be explored. Second, the synthetic genome required an existing cell, M. capricolum, to provide cytoplasm, which contains a variety of life components that could be potentially essential for the function of synthetic genome. Compared to synthesizing DNA, it may be more difficult to reproduce such a complicated cellular environment with all required cellular organs, inorganic elements, organic matters and life macromolecules, such as proteins, carbohydrates and lipids, and the membrane. They play indispensable roles in DNA packaging, transcription, translation, protein expression as well as other cellular functions. Therefore, a synthetic genome itself may not fully represent an "artificial" life; however, this is a significant advancement because it is the genome that contains all inheritable genetic information.
Despite the involved life components, the extensive labor and financial investment, and the safety concerns, this "synthetic" bacterium is undoubtedly a milestone for synthetic biology. M. mycoides has the smallest genome in free-living organisms. It may take a long way to fully realize the dream of creating life, but it can be expected that in the near future, the synthetic procedure will be optimized and the cost will be reduced, which will bring benefits to everyday life and the challenges human beings face, e.g., energy crisis, environmental pollution, and increased CO 2 .
